-
-
-
-
-
-
-
ProMIS Neurosciences (PMN) Files $50M Mixed Shelf
-
-
-
-
-
-
-
ProMIS Neurosciences (PMN) Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases
-
-
-
-
-
-
-
ProMIS Neurosciences (PMN) Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

